To view this email as a web page, click here.
 
FDA WARNINGS
 
Amputation risk possible with diabetes drugs, FDA warns
Based on new data from 2 large clinical trials, FDA is warning that the blockbuster type 2 diabetes medications Invokana, Invokamet and Invokamet XR (canagliflozin) can cause an increased risk of leg and foot amputations.
Read more
 
FDA expands cystic fibrosis treatment
FDA expanded the use of ivacaftor (Kalydeco) to treat cystic fibrosis.
Find out why
 
FDA: Limit codeine and tramadol use in kids
FDA is restricting the use of codeine and tramadol medicines in children. The drug's labels will now include a contraindication that codeine should not be used to treat pain or cough, and that tramadol should not be used to treat pain, in children younger than 12 years.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.